Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:isoniazid
|
| gptkbp:ATCCode |
J04AC01
|
| gptkbp:CASNumber |
54-85-3
|
| gptkbp:contraindication |
gptkb:liver_disease
|
| gptkbp:discoveredBy |
1952
|
| gptkbp:drugClass |
antineoplastic agent
|
| gptkbp:eliminationHalfLife |
1-4 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Laniazid
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits mycolic acid synthesis
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
3767
|
| gptkbp:routeOfAdministration |
oral
intramuscular |
| gptkbp:sideEffect |
peripheral neuropathy
hepatotoxicity |
| gptkbp:UNII |
V83O1VOZ8L
|
| gptkbp:usedFor |
tuberculosis
|
| gptkbp:bfsParent |
gptkb:isoniazid
|
| gptkbp:bfsLayer |
6
|